SG Americas Securities’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38K Sell
15,390
-8,577
-36% -$17.2K ﹤0.01% 3049
2025
Q4
$33K Buy
23,967
+5,456
+29% +$7.2K ﹤0.01% 3410
2025
Q3
$23K Sell
18,511
-76,206
-80% -$90.9K ﹤0.01% 3276
2025
Q2
$107K Buy
94,717
+56,255
+146% +$74.8K ﹤0.01% 2610
2025
Q1
$56K Sell
38,462
-11,472
-23% -$21.6K ﹤0.01% 3209
2024
Q4
$106K Buy
49,934
+2,967
+6% +$7.32K ﹤0.01% 2700
2024
Q3
$132K Buy
46,967
+33,651
+253% +$89.7K ﹤0.01% 2832
2024
Q2
$31K Sell
13,316
-21,842
-62% -$64.4K ﹤0.01% 2738
2024
Q1
$157K Sell
35,158
-18,326
-34% -$76.5K ﹤0.01% 2160
2023
Q4
$172K Buy
+53,484
New +$152K ﹤0.01% 2300
2023
Q2
Sell
-16,172
Closed -$80K 2251
2023
Q1
$80K Buy
16,172
+4,400
+37% +$28.2K ﹤0.01% 2978
2022
Q4
$74K Buy
11,772
+328
+3% +$3.04K ﹤0.01% 2785
2022
Q3
$124K Sell
11,444
-61,063
-84% -$830K ﹤0.01% 2687
2022
Q2
$827K Sell
72,507
-107,111
-60% -$951K 0.01% 1467
2022
Q1
$1.64M Buy
179,618
+55,994
+45% +$583K 0.01% 1057
2021
Q4
$1.84M Buy
123,624
+24,770
+25% +$437K 0.01% 1142
2021
Q3
$2.54M Buy
98,854
+20,440
+26% +$485K 0.01% 1058
2021
Q2
$2.04M Sell
78,414
-3,592
-4% -$102K 0.01% 1108
2021
Q1
$2.9M Sell
82,006
-21,702
-21% -$732K 0.02% 805
2020
Q4
$2.62M Buy
103,708
+80,444
+346% +$2.62M 0.01% 909
2020
Q3
$877K Sell
23,264
-7,168
-24% -$270K 0.01% 1262
2020
Q2
$1.3M Sell
30,432
-21,676
-42% -$784K 0.01% 1156
2020
Q1
$1.01M Buy
52,108
+29,411
+130% +$701K 0.01% 1283
2019
Q4
$590K Sell
22,697
-15,673
-41% -$432K 0.01% 1634
2019
Q3
$1.05M Buy
+38,370
New +$1.09M 0.01% 1379

Other funds holding ALLO